Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD

NeuroImage

Volumn 54, Issue 2, 2011, Pages 985-991

  Vemuri, Prashanthi ^a   Weigand, Stephen D ^a   Knopman, David S ^a   Kantarci, Kejal ^a   Boeve, Bradley F ^a   Petersen, Ronald C ^a   Jack Jr , Clifford R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alzheimer disease; Cox proportional hazards model; Magnetic resonance imaging; Mild cognitive impairment

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; GRAY MATTER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; TEMPORAL LOBE; TIME; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BRAIN; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 78649646271     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.09.004     Document Type: Article

References (35)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC, (DSM IV). 4th Ed.
2. Annesi I., Moreau T., Lellouch J. Efficiency of the logistic regression and Cox proportional hazards models in longitudinal studies. Stat. Med. 1989, 8(12):1515-1521.
3. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
4. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26(3):839-851.
5. Bakkour A., Morris J.C., Dickerson B.C. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009, 72(12):1048-1055.
6. Berkson J., Gage R.P. Calculation of survival rates for cancer. Proc. Staff Meet Mayo Clinic 1950, 25(11):270-286.
7. Bozzali M., et al. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology 2006, 67(3):453-460.
8. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. Suppl. 1996, 165:3-12.
9. Chetelat G., et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005, 27(4):934-946.
10. Devanand D.P., et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007, 68(11):828-836.
11. Fischer P., et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 2007, 68(4):288-291.
12. Fox N.C., et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996, 119(Pt 6):2001-2007.
13. Gomez-Isla T., et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996, 16(14):4491-4500.
14. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 1988, 16:1141-1154.
15. Henneman W.J., et al. Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology 2009, 72(11):999-1007.
16. Jack C.R., et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992, 42(1):183-188.
17. Jack C.R., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52(7):1397-1403.
18. Jagust W., et al. Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann. Neurol. 2006, 59(4):673-681.
19. Kantarci K., et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 2009, 72(17):1519-1525.
20. Knopman D.S., et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann. Neurol. 2005, 57(4):480-488.
21. Landau, S.M., et al., in press. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol. Aging.
22. McDonald C.R., et al. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 2009, 73(6):457-465.
23. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15(1):1-25.
24. O'Quigley J., Prentice R.L. Nonparametric tests of association between survival time and continuously measured covariates: the logit-rank and associated procedures. Biometrics 1991, 47(1):117-127.
25. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256(3):183-194.
26. Petersen R.C. Mild cognitive impairment: current research and clinical implications. Semin. Neurol. 2007, 27(1):22-31.
27. Petersen R.C., et al. Mayo Clinic Alzheimer's Disease Patient Registry. Aging (Milano) 1990, 2(4):408-415.
28. Petersen R.C., et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56(3):303-308.
29. Petersen R.C., et al. Neuropathologic features of amnestic mild cognitive impairment. Arch. Neurol. 2006, 63:665-672.
30. Putter H., Fiocco M., Geskus R.B. Tutorial in biostatistics: competing risks and multi-state models. Stat. Med. 2007, 26(11):2389-2430.
31. Stoub T.R., et al. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 2005, 64(9):1520-1524.
32. Therneau T.M., Grambsch P.M. Modeling Survival Data: Extending the Cox Model 2000, Springer, New York.
33. Van Essen D.C., et al. An integrated software suite for surface-based analyses of cerebral cortex. J. Am. Med. Inform. Assoc. 2001, 8(5):443-459.
34. Vemuri P., et al. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage 2008, 39(3):1186-1197.
35. Whitwell J.L., et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008, 70(7):512-520.